Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01264393 · ClinicalTrials.gov registry record · Phase 3
State-wide Health Approach to Increase Reach and Effectiveness: Study 1
A Phase 3 study of Obesity, sponsored by The Miriam Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT01264393: Completed Phase 3 study of Obesity, sponsored by The Miriam Hospital.
NCT01264393 is a Phase 3 study of Obesity that has completed, run by The Miriam Hospital. The registered enrollment target is 500 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01264393, a Phase 3 study of Obesity, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Behavioral weight loss programs can successfully reduce body weight, but these programs are available to limited numbers of overweight and obese individuals. This project evaluates a unique weight loss approach that combines a self-sustaining weight loss campaign (for outreach) with training in behavioral weight loss strategies and strategies to increase accountability (to improve weight loss success). This innovative combination has the potential to be a cost-effective model for disseminating weight control interventions.
Conditions Studied
Interventions
- BEHAVIORAL Shape Up Rhode Island + Online Resources
- BEHAVIORAL Shape Up Rhode Island + Online Weight Loss Program
- BEHAVIORAL Shape Up Rhode Island + Online Weight Loss Program + Group sessions
Study Locations (1)
Rhode Island
- The Miriam Hospital's Weight Control and Diabetes Research Center - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-03 |
| Phase | Phase 3 |
What the finished NCT01264393 record still lists
NCT01264393 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Shape Up Rhode Island + Online Resources is the first listed.
NCT01264393 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01264393 about?
NCT01264393 is a clinical study titled "State-wide Health Approach to Increase Reach and Effectiveness: Study 1". Behavioral weight loss programs can successfully reduce body weight, but these programs are available to limited numbers of overweight and obese individuals. This project evaluates a unique weight loss approach that combines a self-sustaining weight loss campaign (for outreach) with training in beha...
What is the current status of trial NCT01264393?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 500 participants. The study started on 2011-01. Estimated completion is 2013-03.
What conditions does trial NCT01264393 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT01264393?
The interventions under investigation include: Shape Up Rhode Island + Online Resources (BEHAVIORAL), Shape Up Rhode Island + Online Weight Loss Program (BEHAVIORAL), Shape Up Rhode Island + Online Weight Loss Program + Group sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT01264393?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01264393 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01264393's enrollment target sits among peer trials
500 135th of 1053 higher than 911 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RECRUITING · Phase 3
-
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
RECRUITING · Phase 3
-
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
RECRUITING · Phase 3
-
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RECRUITING · Phase 3
-
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia